These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 33736697)
1. Online marketing practices of regenerative medicine clinics in US-Mexico border region: a web surveillance study. Chavez J; Shah NA; Ruoss S; Cuomo RE; Ward SR; Mackey TK Stem Cell Res Ther; 2021 Mar; 12(1):189. PubMed ID: 33736697 [TBL] [Abstract][Full Text] [Related]
2. Evaluating the Quality of Website Information of Private-Practice Clinics Offering Cell Therapies in Japan. Kashihara H; Nakayama T; Hatta T; Takahashi N; Fujita M Interact J Med Res; 2016 May; 5(2):e15. PubMed ID: 27222494 [TBL] [Abstract][Full Text] [Related]
3. Direct-to-consumer marketing of stem cell interventions by Canadian businesses. Turner L Regen Med; 2018 Sep; 13(6):643-658. PubMed ID: 30255734 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 Treatments Sold Online Without Prescription Requirements in the United States: Cross-sectional Study Evaluating Availability, Safety and Marketing of Medications. Ozawa S; Billings J; Sun Y; Yu S; Penley B J Med Internet Res; 2022 Feb; 24(2):e27704. PubMed ID: 34662286 [TBL] [Abstract][Full Text] [Related]
5. Assessing "Cell Therapy" Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States. Nirwan RS; Albini TA; Sridhar J; Flynn HW; Kuriyan AE Ophthalmology; 2019 Oct; 126(10):1350-1355. PubMed ID: 30904542 [TBL] [Abstract][Full Text] [Related]
6. Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites' marketing of stem cell therapies. Murdoch B; Zarzeczny A; Caulfield T BMJ Open; 2018 Feb; 8(2):e019414. PubMed ID: 29490963 [TBL] [Abstract][Full Text] [Related]
7. Global reach of direct-to-consumer advertising using social media for illicit online drug sales. Mackey TK; Liang BA J Med Internet Res; 2013 May; 15(5):e105. PubMed ID: 23718965 [TBL] [Abstract][Full Text] [Related]
8. Beyond "medical tourism": Canadian companies marketing medical travel. Turner L Global Health; 2012 Jun; 8():16. PubMed ID: 22703873 [TBL] [Abstract][Full Text] [Related]
9. Update on "Cell Therapy" Clinics Offering Treatments of Ocular Conditions Using Direct-To-Consumer Marketing Websites in the U.S. Kalavar M; Lovett EA; Nicholas MP; Ross-Hirsch A; Nirwan RS; Sridhar J; Patel S; Flynn HW; Albini TA; Kuriyan AE Am J Ophthalmol; 2024 Nov; 267():135-141. PubMed ID: 38880376 [TBL] [Abstract][Full Text] [Related]
10. Uncovering the gray zone: mapping the global landscape of direct-to-consumer businesses offering interventions based on secretomes, extracellular vesicles, and exosomes. Asadpour A; Yahaya BH; Bicknell K; Cottrell GS; Widera D Stem Cell Res Ther; 2023 May; 14(1):111. PubMed ID: 37138298 [TBL] [Abstract][Full Text] [Related]
11. Stem cell tourism--a web-based analysis of clinical services available to international travellers. Connolly R; O'Brien T; Flaherty G Travel Med Infect Dis; 2014; 12(6 Pt B):695-701. PubMed ID: 25449045 [TBL] [Abstract][Full Text] [Related]
12. Open for business: a comparative study of websites selling autologous stem cells in Australia and Japan. Munsie M; Lysaght T; Hendl T; Tan HL; Kerridge I; Stewart C Regen Med; 2017 Oct; 12(7):777-790. PubMed ID: 29125016 [No Abstract] [Full Text] [Related]
13. Measuring reproductive tourism through an analysis of Indian ART clinic Websites. Deonandan R; Loncar M; Rahman P; Omar S Int J Gen Med; 2012; 5():763-73. PubMed ID: 23049270 [TBL] [Abstract][Full Text] [Related]
14. Businesses marketing purported stem cell treatments and exosome therapies for COVID-19: An analysis of direct-to-consumer online advertising claims. Turner L; Martinez JR; Najjar S; Rajapaksha Arachchilage T; Wang JC Stem Cell Reports; 2023 Nov; 18(11):2010-2015. PubMed ID: 37890484 [TBL] [Abstract][Full Text] [Related]
15. US businesses engaged in direct-to-consumer marketing of perinatal stem cell interventions following the Food and Drug Administration's enforcement discretion era. Turner L; Wang JC; Martinez JR; Najjar S; Rajapaksha Arachchilage T; Sahrai V Cytotherapy; 2024 Apr; 26(4):393-403. PubMed ID: 38340106 [TBL] [Abstract][Full Text] [Related]
16. Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies. Turner L; Martinez JR; Najjar S; Arachchilage TR; Sahrai V; Wang JC Regen Med; 2023 Nov; 18(11):857-868. PubMed ID: 37867326 [No Abstract] [Full Text] [Related]
17. Regenerative therapies for erectile dysfunction: the influence of direct-to-consumer marketing on patient interest. Yang SC; Weinberger JM; Shahinyan RH; Shahinyan GK; Mills JN; Eleswarapu SV Transl Androl Urol; 2023 Apr; 12(4):586-593. PubMed ID: 37181238 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy claims made by US businesses marketing purported stem cell treatments and exosome therapies. Turner L; Martinez JR; Najjar S; Arachchilage TR; Sahrai V; Wang JC Regen Med; 2023 Oct; 18(10):781-793. PubMed ID: 37795701 [No Abstract] [Full Text] [Related]
19. Online Pharmacy Accessibility of Imatinib, An Oral Chemotherapy Medication. Sun Y; Hendrix A; Muluneh B; Ozawa S J Natl Compr Canc Netw; 2022 Jul; 20(7):808-814. PubMed ID: 35830891 [TBL] [Abstract][Full Text] [Related]
20. Canadian medical tourism companies that have exited the marketplace: Content analysis of websites used to market transnational medical travel. Turner L Global Health; 2011 Oct; 7():40. PubMed ID: 21995598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]